Perimeter Medical AI CEO to Outline Commercial Strategy at MicroCap Showcase
Event summary
- Perimeter Medical Imaging AI CEO Adrian Mendes to present at Planet MicroCap Showcase on June 17, 2026.
- Presentation to cover commercial strategy and upcoming milestones.
- Live and archived webcast available on company website.
- Claire™ OCT System recently received FDA approval for breast cancer surgery imaging.
- Company listed on TSXV (PINK) and OTCQX (PYNKF).
The big picture
Perimeter's participation in the Planet MicroCap Showcase comes as the company looks to capitalize on its recent FDA approval for the Claire™ OCT System. The event provides a platform to articulate its commercial strategy to microcap investors, who are increasingly focused on medtech innovations addressing unmet clinical needs. The presentation will be critical in gauging market appetite for Perimeter's technology as it competes with larger players in the surgical imaging space.
What we're watching
- Commercial Execution
- How Perimeter will scale adoption of its FDA-approved Claire™ system in breast cancer surgery.
- Market Differentiation
- Whether Perimeter can maintain competitive advantage in AI-assisted surgical imaging.
- Investor Engagement
- The pace at which Perimeter converts conference interest into tangible investor relationships.
Related topics